Physician profile
Katrina D Powers
NPI 1588622153
$1,302.52
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,181 · 2020: $103 · 2021: $18.15.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $217.73 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $158.92 | 2019 | |
| Amgen INC. | $149.44 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $122.69 | 2019-2020 | |
| Amarin Pharma, INC. | $117.32 | 2019-2020 | |
| Allergan, INC. | $62.07 | 2019 | |
| Shire North American Group INC | $57.76 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.08 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.08 | 2019 | |
| Alimera Sciences, INC. | $32.19 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.82 | 2019 | |
| Antares Pharma, INC. | $29.06 | 2019-2020 | |
| Radius Health, INC. | $24.43 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $23.76 | 2019 | |
| Philips North America LLC | $20.17 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $18.15 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.23 | 2019 | |
| Astellas Pharma US INC | $15.55 | 2019 | |
| Ibsa Pharma INC. | $15.18 | 2019 | |
| Adlon Therapeutics L.P. | $15.16 | 2019 | |
| Therapeuticsmd, INC. | $15.07 | 2019 | |
| Assertio Therapeutics, INC. | $13.69 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $13.58 | 2019 | |
| Lilly USA, LLC | $13.26 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.71 | 2019 | |
| Novo Nordisk INC | $11.42 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.